Dieter Weinand is the former CEO of Bayer Pharma AG and is an experienced business leader with over 25 years of experience in the pharmaceutical industry. Mr. Weinand earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York. During a career stretching back over 25 years, Mr. Weinand has held various responsibilities in general management, commercial, operational, and strategic leadership roles, leading business operations globally, for companies including Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi. Mr. Weinand also led the launch and marketing of products across numerous therapeutic categories, including primary care and clinical sub-specialties, including oncology. Mr. Weinand is currently Chairman of the Board of Replimune (REPL), Member of the Board of Directors of Reunion Neuroscience (REUN), Chairman of the Board of Directors of ForeBio, Chairman of the Board of Mnemo, and Executive Chairman of the Board of ZielBioPharma.